Violation of prophylactic vancomycin administration timing is a potential risk factor for rate of surgical site infections in cardiac surgery patients: a prospective cohort study

Paolo Cotogni(Azienda Ospedaliero Universitaria San Giovanni Battista), Mauro Rinaldi(Azienda Ospedaliero Universitaria San Giovanni Battista), Cristina Barbero(Fondazione Ricerca Molinette), G Olivero(University of Turin), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Lucina Fossati(Istituto Superiore di Sanità)
BMC Cardiovascular Disorders
March 8, 2017
10.1186/s12872-017-0506-5
Cited by 22

Related Papers

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
|Leukemia|2013|305
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
|Blood|2011|268
Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
|Journal of Clinical Oncology|2010|268
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage
|Blood|2008|253